Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis - NCT00413699-Goiania - 006 (Clinical Trial 158997)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy158997.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Goiania |
|
Country:
|
|
Brazil |
|
|
|
| Conditions: |
|
Arthritis, Rheumatoid |
| Purpose: |
|
The purpose of this study is to determine the long-term effectiveness and safety of
CP-690,550 for the treatment of rheumatoid arthritis. Subjects are only eligible for this
study after participating in another "qualifying" study of CP-690,550
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Subjects who have participated in a randomized "qualifying" study of CP-690,550 for
the treatment of rheumatoid arthritis
Exclusion Criteria:
- Serious medical conditions that would make treatment with CP-690,550 potentially
unsafe |
|
|
|
| Study is available at: |
|
Pfizer Investigational Site
Goiania
Brazil
Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 3, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|